Article
Plasmodium vivax vaccine candidate MSP1 displays conserved B-cell epitope despite high genetic diversity.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases - 1 Sept 2021
Ghoshal Sharmistha, Datta Kanjilal Sumana, Sengupta Sanghamitra
Abstract excerpt
The polymorphic nature of merozoite surface protein 1(MSP1) raises doubts whether it may serve as a vaccine target against Plasmodium vivax malaria. This study analyses the impact of genetic variability on the epitope organization of different Pvmsp1 blocks. Ten blood samples collected from P. vivax infected malaria patients from West Bengal, India were used to analyze sequence and antigenic diversities of block...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
